Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000281 · ClinicalTrials.gov registry record · Phase 2
Pharmacotherapy for Schizophrenic Drug Users - 6
A Phase 2 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00000281: Completed Phase 2 study, sponsored by Yale University.
NCT00000281 is a Phase 2 study that has completed, run by Yale University. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00000281, a Phase 2 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
The purpose of this study is to evaluate maintenance neuroleptics for Schizophrenic patients who are cocaine abusers.
Interventions
- BEHAVIORAL Amantadine
Trial Details
| Field | Value |
|---|---|
| Start Date | 1994-09 |
| Est. Completion | 1999-08 |
| Phase | Phase 2 |
What the finished NCT00000281 record still lists
NCT00000281 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Amantadine is the first listed.
NCT00000281 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00000281 about?
NCT00000281 is a clinical study titled "Pharmacotherapy for Schizophrenic Drug Users - 6". The purpose of this study is to evaluate maintenance neuroleptics for Schizophrenic patients who are cocaine abusers.
What is the current status of trial NCT00000281?
This trial is currently completed. It is a Phase 2 study. The study started on 1994-09. Estimated completion is 1999-08.
What interventions are being tested in trial NCT00000281?
The interventions under investigation include: Amantadine (BEHAVIORAL).
Who is sponsoring clinical trial NCT00000281?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia